Journal
RADIATION ONCOLOGY
Volume 6, Issue -, Pages -Publisher
BMC
DOI: 10.1186/1748-717X-6-94
Keywords
18F-FDG-PET/CT; anaplastic meningioma; 111In-DTPA-octreotide; radio receptor therapy
Ask authors/readers for more resources
A patient with anaplastic meningioma and lung metastases resistant to conventional treatment underwent radiopeptide therapy with 177Lu-DOTA-octreotate in our institute. The treatment resulted in significant improvement in patient's quality of life and inhibition of tumor progression. This case may eventually help to establish the value of radiopeptide therapy in patients with this rare condition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
